SLS
Sellas Life Sciences Group Inc
Mentions (24Hr)
66.67% Today
Reddit Posts
$SLS $MRK Partnership supply agreement signed with Merck Merck & Co., Inc. Basket Study SELLAS entered into a Clinical Trial Collaboration and Supply Agreement for the conduct of a combination clinical trial Merck & Co., Inc., Kenilworth, N.J., USA ......
Phase 3 Fda Registrational Trial Results are Incoming - a Virtual lock, and worth 100X Plus, the current short rigged market value. Check out all the Short Lowlife all over social media. $SLS is on the Launch Pad.
GFH009 / SLS009 is Shaping up to be a true Miracle Cure for AML patients
Is GFH/SLS009 a Miracle AML Cure? It sure is shaping up to be.
Gps Phase 3 Trial Results for AML remission patients Finally coming in $SLS
Seelos Therapeutics Announces Encouraging Data from an In Vivo Study of SLS-005 in an Aggressive Preclinical Model of Alzheimerβs Disease
Seelos Therapeuticsl (NASDAQ: SEEL) SLS-009 has the potential to be a product-in-a-pipeline
Seelos Therapeuticsl (NASDAQ: SEEL) SLS-009 has the potential to be a product-in-a-pipeline
Seelos Therapeuticsl (NASDAQ: SEEL) SLS-009 has the potential to be a product-in-a-pipeline
Seelos Therapeuticsl (NASDAQ: SEEL) SLS-009 has the potential to be a product-in-a-pipeline
Overview SLS Investment Opportunity - Thesis for a $3B Buyout within the next 12 months.
SLS - Beyond Ready for Move Higher & Explanation $36.49-$48.66 (Fair Price)
SLS, shorted back when it was 1-2$ book price 35$-42$. Volume way too low. Thoughts?
SLS, book price 35-42$, highly shorted stock. Volume ridiculously lower than it should be.
SLS - Beyond Ready for Move Higher & Explanation $36.49-$48.66 (Fair Price)
SLS - Huge Pop Incoming & Explanation $36.49-$48.66 (Fair Price)
SLS - Huge Pop Incoming & Explanation $36.49-$48.66 (Fair Price)
$SLS Time for a Run - KOL let it slip FDA approval is a Lock for AML remission patients.
$SLS is about to go 100% to 5+ by end of week.
SEEL - Seelos Therapeutics and why itβs worth your time
SEEL - Seelos Therapeutics and why itβs worth your time
Seelos Therapeutics Announces Statistically Significant Data in a Gene Therapy Study of SLS-004 in Dementia with Lewy Bodies
Is it a good move to invest in copper stocks now?
Rejoining the $FATH: A DD Part 2 - Squeeze + Value
Rejoining the $FATH: A DD Part 2 - Squeeze + Value
If SLS had a good amount of sudden buying volume it would see massive gains.
The Story of $CNTX (250k float) VOLATILE
$CNTX. Big boob cancer cure, big buys by the CEO, big news coming soon. The only thing that's micro is the float.
$CNTX. Big boob cancer cure, big buys by the CEO, big news coming soon. The only thing that's micro is the float.
$SEEL GETS Fast Track Designation for SLS-005
255% upside from 3 price targets on $SLS
FUTURE of Oncology Immunotherapy + Short Squeeze
I just invested in copper stocks. Should I be worried about the volatile situation when it comes to prices?
Will the recent copper shortage be an opportunity for smaller miners?
Will the recent copper shortage be an opportunity for smaller miners?
Will the recent copper shortage be an opportunity for smaller miners?
Cancer Vaccine... is that even the right term?
SLS Real Price mismatch from Market Price - Should be $32.62+
SLS has 3 PT from $16.50-$21, Shouldn't be anywhere close to $146 million market cap
Mining companies and engaging with communities and environmental advocacies
Solaris Resourcesβs Warintza Project is showing potential to become a bigger project than Anglo Americanβs Quellaveco
Solaris Resourcesβs Warintza Project is showing potential to become a bigger project than Anglo Americanβs Quellaveco
Tutes are loading $SLS and screwed Retail after 6/30... REGAL study event August 17th with REGAL Steering Committee Member joining management!
$SLS shorts know they are in trouble going into the August 17th Symposium. π
SLS - SELLAS Life Sciences to Host Virtual Investor Symposium on its Lead Asset, Galinpepimut-S, on August 17, 2021
SLS Is ready to begin GPS manufacturing soon?
SLS Ramping Up Manufacturing - In the Middle of Trials - π€π
wow the SLS shorts really don't know when to call it quits, average PT is $18.50 right now
Thoughts on senior and junior copper mining stocks
Massive Abuse of Dark Pools and Short Volume - SLS Low Float
Ecuador as a booming major mining investment destination
Best short term investment I have seen in a long time. $SLS πππ
$SLS to Moon. Pre-Market jumped 22%
SLS Sellas Life Sciences Group BREAKING OUT NOW π₯π₯π€π€
13 trading days left. $SLS has two trial data sets release between now and June 30th. Massive squeeze to near term $73 PT incoming!
People only talk about AMC, but the news on AMC is simple: buy and hold; what about SLS?
$SLS shorts when they realize they fucked up shorting a Cancer Cure! Two trial data releases before end of June. LETS GO APES!!! LETS CURE CANCER!!! πππ¦πππ¦
APES CURING CANCER!!! $SLS Naked Shorts are Screwed! π¦πππ€ππ
$SLS to da moon π .... LETS GO APES! WE CAN CURE CANCER!!! π¦πππππ°ππ€«
APES CURING CANCER. So many naked shorts on $SLS and they deserve to be slaughtered. π¦π LETS GO!!!
APES CURING CANCER. So many naked shorts on $SLS and they deserve to be slaughtered. Near Term PT $73. π¦ππ¦ππ¦π LETS GO!!!
APES are totally going to CURE CANCER!!! $SLS has so many naked shorts right now. LET'S GO!!! π¦ππ¦ππ¦π
LETS GO APES!!! $SLS low float, over shorted, shorts are scared and it's primed to breakout! Lets Cure Cancer!!!
What happens when all those $SLS naked shorts from December and February have to cover on this tiny 15 million float. Tell me if you can see it in the chart. $73 Near Term PT
APES CAN CURE CANCER! $SLS Two Major Trial Data Release Before June 30th. APES STRONG LETS GO!!! Way too many shorts targeting a cancer cure.
$SLS shorts appear to be giving up and itβs setting up and epic short squeeze for next week! Letβs go APES!!! π€ππ¦πππ°
$SLS this is why you HODL!!!! Fuck those hedge funds shorting Cancer Cures!!! π¦ππ°π€πππ
$SLS I have never seen a stock break the top level bollinger and not explode higher but instead, just hover at the top... especially on a weekly scale after they've compressed as much as they did. Time for this MM and hedge funds to get destroyed for manipulation. LETS GO APES!!! π¦ππ°π€πππ
For too long hedge funds have target Cancer Cures to prevent them from getting to market. Time to end their Cancer Treatment money train! $SLS has two major trial data hitting before the end of June. The time to strike is now!!! APES STRONG!!! π¦ππ°π€πππ Only 15 million shares total.
Short Infestation Problem with $SLS. Seriously who targets a Cancer Cure! APES STRONG!!! ππππ°π€π¦
Sellas Life Sciences price target raised to $16.50 from $8 at Alliance Global Partners $SLS
$SLS Huge Price Target Upgrade!!!! $16.5 Lets GO APES!!! ππππππ€π°π
Did they really think that dip would shake us of our $SLS shares hahahaah they set the stage for two trial data release between now and the end of June. Real APES HODL!!! ππ€ππππ
Better Percentage Gain Tomorrow?
$SLS Shorts are Nervous!!! How fast can they cover on a 15 million float!
$SLS they've messed with the wrong cancer curing company! LETS GO APES!
$SLS shorts are totally trapped with Short Sale Restriction Turned On!
Shorts on full attack mode on $SLS... LETS GO APES!
APES on the move to take out $SLS Shorts! CEO speaking right now to help attack them!
APES Taking $SLS Cancer Cure to da Moon!!!
$SLS when they announce their Cancer Cure at 8:30 today!
$SLS shorts targeting a cancer cure announcement today at 8:30 have no idea what they are doing.
APES Curing Cancer by mauling $SLS Shorts today!
Next Epic Squeeze Setup - Vote
Mentions
Wasn't it kinda obvious? There is another pump and dump called SLS for those interested.
John Tuld in Margin Call: "it sure is a hell of a lot easier to just be first." Reading headlines *then* acting, I've lost nearly as often as I've won. For every FEIM (51%) or ABOS (37%) there's a WWR (-53%) or a TMC (-20%). Knowing a bit about emerging tech, trends, and development cycles lets you get ahead of the curve or spy slept-on details, and the you can accumulate for 200-800% runs (e.g. PLSR, HGRAF, SLS, ADEX, formerly NUAI).
Woke up Became an SLS bag holder in 2 hours Back to sleep
Market never makes sense. SLS runs all the time with no news at all. Then, good news this morning and it drops lol
SLS news https://ir.sellaslifesciences.com/news/News-Details/2026/SELLAS-Life-Sciences-Announces-Enrollment-of-First-Patient-in-Newly-Diagnosed-First-Line-AML-Trial-of-SLS009/default.aspx
How did you even find SLS and IBRX? Both stocks have exploded
So if USA said they sending a man to the moon tomorrow it's Iranian hubris to point out that SLS is rolling back to VAB for duct tape due to leaks and starship doesn't look like it's gonna work anytime soon.
IBRX/EONR/SLS probably. Atm iβm focusing EONR cuz I believe theres ugly truth behind all the manipulative news articles US trying to put out and they already got caught multiple times. IBRX only if u can wait most likely until ~2028-2030+ NFA.
Thank you, glad the due diligence is helpful and insightful. And Yes, I am still accumulating and adding every week, with fully diluted share counts of 217MM to 225MM, the upside from $6 a share is 6X to 29X. For context, GPS annual sales will be at least $4B to $5.5B+ globally and GPS + SLS-009 will be $6.5B to $8.5B. GPS extends survival to 30-40+ months (as the REGAL data implies), and then there's the cure fraction we are seeing, that the machine learning model predicted is 64%. LTV estimate just based on the long-term survival (and not "cured") is: β$260K (Y1) + $100K (Y2) + $100K (Y3) + $50K (Y4/Tail) = $510K Total LTV. $510K Γ· 3.5 years = $145K annual revenue per patient. The most interesting thing is new transplant ineligible patients in the U.S. (not including globally): There's only about 3,000 new CR2 and 6,000 new CR1 patients each year. (it is more globally) If everyone mostly died in 8 months (like they do now), revenue would be small ($260K Γ 9,000 = $2.3B max). Because GPS keeps patients alive for 3-4 years, by Year 4, you aren't just treating the new patients. You are treating: 2026 survivors (Year 3 of dosing) 2027 survivors (Year 2 of dosing) 2028 new starts (Year 1 of dosing) This is what creates the 27,000 patient pool and the $4.0B+ annual revenue (and globally will be more, likely $5.5B+ total globally) 4 x 3 to 5 Peak Sales (standard for general acquisitions in Bio) is 20B for example, and this is a breakthrough in oncology (where these types of assets are acquired for 6 to 8 times peak sales). The floor really is 10B, but I just said 6B because I'm a deep value investor and always assume worst case scenarios. Buyout range is 6B to 40B. Fully diluted share counts is 217MM to 225MM, so 10B would be about $46.40 a share. The range is that broad for buyout because we ultimately don't know what the bidding war between strategics like ABBV, BMS, etc. will lead to, as we're just talking about GPS here for AML CR2 and CR1. We haven't even discussed SLS-009 (which will be bigger than GPS) for the Frontline, which is in Phase 2B, we haven't talked about the other indications from the WT1 targeting that is present in 20+ cancers, etc.
Yes, I am still accumulating and adding every week. with fully diluted share counts of 217MM to 225MM, the upside from $6 a share is 6X to 29X. For context, GPS annual sales will be at least $4B to $5.5B+ globally and GPS + SLS-009 will be $6.5B to $8.5B. GPS extends survival to 30-40+ months (as the REGAL data implies), and then there's the cure fraction we are seeing, that the machine learning model predicted is 64%. LTV estimate just based on the long-term survival (and not "cured") is: β$260K (Y1) + $100K (Y2) + $100K (Y3) + $50K (Y4/Tail) = $510K Total LTV. $510K Γ· 3.5 years = $145K annual revenue per patient. The most interesting thing is new transplant ineligible patients in the U.S. (not including globally): There's only about 3,000 new CR2 and 6,000 new CR1 patients each year. (it is more globally) If everyone mostly died in 8 months (like they do now), revenue would be small ($260K Γ 9,000 = $2.3B max). Because GPS keeps patients alive for 3-4 years, by Year 4, you aren't just treating the new patients. You are treating: 2026 survivors (Year 3 of dosing) 2027 survivors (Year 2 of dosing) 2028 new starts (Year 1 of dosing) This is what creates the 27,000 patient pool and the $4.0B+ annual revenue (and globally will be more, likely $5.5B+ total globally) 4 x 3 to 5 Peak Sales (standard for general acquisitions in Bio) is 20B for example, and this is a breakthrough in oncology (where these types of assets are acquired for 6 to 8 times peak sales). The floor really is 10B, but I just said 6B because I'm a deep value investor and always assume worst case scenarios. Buyout range is 6B to 40B. Fully diluted share counts is 217MM to 225MM, so 10B would be about $46.40 a share. The range is that broad for buyout because we ultimately don't know what the bidding war between strategics like ABBV, BMS, etc. will lead to, as we're just talking about GPS here for AML CR2 and CR1. We haven't even discussed SLS-009 (which will be bigger than GPS) for the Frontline, which is in Phase 2B, we haven't talked about the other indications from the WT1 targeting that is present in 20+ cancers, etc.
First stock i ever brought was puregold canada right before covid hit @ 50c per share. Sold all of it a yr later for 2x gain. It was interesting because i was 100% sure we are going into lockdown and QEing & the company was at its final stage of development before production. People were laughing at me for preparing for black swan & buying gold mining as spot were quite low at 1200 2nd major purchase was GME, but at peak hype. Lost 50% of my portfolio. Believed it as there were a lot of research went into it. Learned quite a bit from this. Decide to never touch short squeeze ever again 3rd major purchase was BB a few years ago, as it was about to become profitable. QNX and their cybersecurity suite seemed quite interesting with potential. Ultimately realized the company is heavily shorted and the management is having a hard time increasing their profit. Sold at a slight loss a yr later Then it was rigetti. Brought at 50c again. Thought eventually thereβ going to a quantum boom. Sold 6mo later when it hit $7. When i say eventually i didnt meant in 6mo lol, sold for quite a nice profit and will jump back in once itβ actually at a reasonable valuation. Currently invested heavily in PNG, FLT, ONDS, JAG & SLS since 1yr ago. Reason why i invested to these? Similar to puregold canada with covid. Felt thereβ something major is happening since the start of trumpβ 2nd term. Felt canada and the rest of the world will move away from US, and the war in Ukraine will popularize drones. Of course also because they are good companies. Lesson i learn from the past 7yrs. A good financial make a good company, but doesnt meant it would be a great investment for the short 1-2yr term, same with tech & IPs. Now days i invest more into future trends, looking for companies most investors wont touch but excel in their own niche fields with good management and improving financials
how long do I hold SLS for
Honestly getting tired of trading in this environment. Might just go big on SLS LEAPs and spend time with my family.
DRTS is a method/device (a tiny dart injected into the tumor in a reverse of the way you would take a biopsy, it contains a very low dose of radiation that has a dispersal of radiation to a very small area to impact the tumor while sparing healthy tissue, the dart/darts are later removed), IBRX is immunotherapy. There is room for DRTS and IBRX and SLS, the more treatment options (solo or in combination) to allow effective treatment, the better.
Not $3 a share but two I think that have potential: SLS: there's many people already in this, excellent potential and a catalyst is due at any point. If you do enough digging through Reddit you'll find out why people are so bullish on it. UNCY: UNCY has a drug that makes the pill burden for those with chronic kidney issues much easier to handle, usually people with these issues take upwards of 12 pills a day, but with UNCY it reduces it rapidly to 3 pills per day. The drug had excellent results during clinical trials. Last year it was due for FDA approval but failed, not because the drug had issues but because the supplier they had who was manufacturing had many issues so they failed due to that. In December the company disclosed these issues have now been resolved, and they're expecting another FDA verdict around June time. If approved this could really fly
Guys ngl but I made more by holding biotech pennies... sucha blessing! ex pennies: RCKT IBRX SLS
Gonna ride out the last of this SLS wave everyone was sleeping on.
Been hiking SLS for a while. Just got into TNYA. Small risk play based on their upcoming earnings and new contract.
So many people pushing this junk across several different subs. Recover your losses in SLS, IBRX, or TNYA.
SLS has been a real beauty queen
SLS baby. Holding this thing since 1.80. Sky is the limit
Going to stick with buying IBRX and SLS like every day in the dips.
Guys I made 9k so what do I do. I inversed WSB and went full calls cuz market hates yall. I was thinking of full porting SLS but price seems a lil high rn
By community members so you mean rich people? SLS is a winner
SLS gonna create a lot of βcommunity membersβ I can see it coming.
SLS breaking 6 with no news lol
SLS up 10% on the day and looking to keep creeping up. I am surprised more people on not jumping on this. Up over 230% in the last 3 months!
I see 6 comments about SLS. Are we allowed to talk about this one openly, or might it still result in a ban? Honest question.
SLS train is departing, get on before itβs too late
SLS is carrying my port
SLS Sellas what judt happened there? Also today's GME chart looks dreamy
Ohhh I see now ... it gave you a company with the 100 million -2 billion upside potential... the hottest drug right now is **Peptide**Β **injections**Β and capsule . they are right in the middle SLS . Keep watching it
where and how did you find this company SLS ? ... Very good
**SLS (SELLAS Life Sciences Group, Inc.)** Recent developments include: * Positive momentum from the **Phase 3 REGAL trial** of GPS in AML maintenance therapy. Updates (e.g., late 2025/early 2026) showed slower event rates (e.g., 72 events reported, with final analysis expected at 80 deaths), interpreted positively as a signal of efficacy. The trial is event-driven and on track, with potential readout imminent (analysts note it as a major catalyst, possibly driving priority FDA review if successful). * Encouraging Phase 2 data for SLS009 + azacitidine/venetoclax in relapsed/refractory AML (e.g., 46% overall response rate in certain patients), presented at conferences like ASH 2025. * Expansion of SLS009 program: Agreement with IMPACT-AML (January 2026) to extend clinical trials into Europe for frontline AML, enabling broader enrollment (U.S. starting Q1 2026, Europe Q2). * Financing moves, like warrant exercises for proceeds. * Stock has surged significantly (e.g., hitting multi-year highs around $5.50β$5.66 in early March 2026), up sharply in recent months on trial optimism, with a market cap around $780β$790M and analyst targets suggesting further upside (e.g., \~$6β$7).
They're are many DDs on their subreddit. Sorry story: they have all three shown remarkable results. Drts has Japanese approval for 1 type of cancer recently with more trials and approvals hopefully imminent. SLS has two very promising drugs in the pipeline and trials for many different conditions. One trial isn't ending because way less people have passed than expected so far. Ibrx has approval for one kind of cancer in USA, UK, EU and Saudi Arabia and also for lung cancer in SA.
buy SLS you'll get your 5K back in 3 months
SLS. You better be quick, cause it's not likely to stay at its current levels.
Lol thatβs hilarious that people remember my comments. All I remember is arguing with people on this sub that HGRAF and SLS arenβt scams and here we are. Almost all of them deleted their comments.
After the halt I sold in the high 4s and moved profits to SLS leaps. I am looking to reenter if this dips some more
im throwing a sweaty orgy with gold, SLS, and PL
Crazy that these stocks can really bring life/situation changing money if you are onboard the right play. I know you typically don throw your life savings on a stock but you see stocks like DXST hit 100+% today. That is amazing. I recognize it can also go the other way. Just a cool thing to be apart of. Been a lot more conservative this week and mainly holding SLS AND IBRX. Perhaps should jump into other plays that are bringing in money, but even sitting out it is dope to see hopefully some of yall my fellow reddit apes are making some money.
βShaqballsβ is kind of memorable π. I got in early on SLS, early and holding SCD as well. In a time where so many investors are panicking, Iβve had the best returns of my life and have to credit Reddit and real posters like you. Lots to weed through but it has been so helpful. Not familiar with RZLV. Iβll check it out. Thanks for sharing!
SLS, CING, ANNA! Easiest question ever!
i'll never care or know what SLS is or what it does. all that matter is it isn't SLV
If there are new traders who have the PTD limit (for now) and got caught lacking, as it happens to the best of us, a really good play you can run with is checking out penny stocks above 100M market cap. Stocks like ALTO, BTFY, TNYA and now SLS and LRMR making their way up the totem pole are great examples of trusting news, sitting back, and enjoying the swing. If volatility crushes you, you can always look there for a slow 20-30% gain, maybe even 100% like IBRX the past month or 1,000% if you held it on since it was almost under $2 (Papaya is a real one for this stock).
Hey, hope you got into SLS around this time!
Yep. Thanks for remembering. I was beating the drums on both for months while people talked shit calling them scams π€£ if I was petty Iβd have alot of receipts but Iβm just happy with my returns. Next is RZLV and SCD fyi. Not to the same level as SLS and HGRAF because they are both life changing but SCD will go to dollar land this year or next and RZLV is at least a 5xer. Not pump and dumps but legit companies. GL
Youβre holding SLS and HG! You are doing very well my friend! Wow.
SLS, slowly stacking.
Anyone here going to buy the SLS dip? They've got a potential fda approval sometime soon haven't they? Could be great.
SLS, before you ask why read about Regal Phase 3 Trial that should give you some of the reasons why. GLTA
SLS , the longer we donβt get results from the phase 3 trial the better
1000 shares of SLS and hold for the potential buyout. Add some risk.
HGRAF, ADUR, SLS. Everything else is noise
Why is $SLS not on the top 6 tickers yet? Itβs trending number 1 all day
Thereβs is so much DD you can read on how this is basically guaranteed to work that Iβm not even going to get into it. Yes, itβs a biotech. Yes there are many that fail but out of those many there are always those handful of diamonds in the rough. SLS AS WELL AS IBXR are those diamonds. I canβt speak for other victor stocks as Iβve only been monitoring these two. Though I hear DRTS is also looking at a bright future.
Unfortunately not, I only came across this post today when researching SLS. Great call sir!
why do I feel like half the SLS pumpers are bots here
what are short term and long term predictions for ASPI? is it considered βsafeβ like SLS and IBRX
SLS and ASPI are awesome, not sure I believe in the other two.
Look into SLS, GANX, IBRX, and ASPI
Hoping SLS drops below $5 so I can load up.
Iβm sticking with SLS
Are penny stocks against the rules here? HGRAF and SLS have been good to me lately.
SLS only thing green for me today
SLS is like 70% of my portfolio. Anything else going on in the world this week?
SLS nothing more, nothing less.
To all my long SLS holders...let's fucking go!
Screw the big Caps. Full port SLS for the BO! 